Contamination of sink traps and patients by P. aeruginosa. During the 10 months of the study, the 13 sink traps of the MICU were sampled 42 times each, for a total of 546 samples, of which 282 (51.6%) were positive for one or more isolates of PA. This led to the collection of 404 environmental isolates. All sink traps were positive for PA at some point of the study and could be contaminated with multiple STs (mean: 5, min: 2, max: 10), with clones persisting in each sink trap for long periods of time (mean: 242 days, max: 286 days). Among the 549 patients included, 65 (11.8%) were positive for PA. We collected 115 clinical isolates from these patients during their hospitalization. Three patients (3/65, 4.6%) were infected with PA.
Population structure of P. aeruginosa. The 519 isolates were distributed within 62 different STs, with five STs accounting for 54.9% of the entire collection. Hence, the high-risk clones ST253, ST308, ST298, and ST244 were represented by 90 (17.3%), 69 (13.3%), 39 (7.5%), and 32 (6.2%) isolates, respectively, and ST309 was represented by 55 isolates (10.6%) (Supplemental Table 1). Isolates from sink traps and patients were distributed within 27 and 48 different STs, respectively, with 13 STs in common. We then compared the clonal diversity of the population of isolates retrieved from the sink traps with that of the clinical isolates and found that the community of clinical PA was 4.1-times richer and 2.6-times more diverse than that retrieved from the sink traps (Supplemental Fig. 2).
Transmission routes of P. aeruginosa. The routes of transmission of PA within the MICU were accurately identified by comparing the genomes of all isolates with a pipeline that allowed variant calling. This method clustered the isolates into 36 groups (Supplemental Fig. 3). We combined these genomic data with spatiotemporal data to identify intra- and inter-reservoir transmission events (Table 1, Fig. 2).
Table 1
Details of the transmission of P. aeruginosa isolates involving patients in the medical intensive care unit at Besançon University Hospital (France) between January and November 2019.
Type of transmission
|
Isolate (ST, group)
|
Resistance phenotype
|
Reservoir 1
|
Room
|
Date (2019)
|
Direction of transmissiona
|
Reservoir 2
|
Room
|
Date (2019)
|
Patient-to-patient
|
|
ST198, group34_1
|
FQsb
|
Patient43
|
A1
|
Apr. 14
|
Unknown
|
Patient49
|
A1
|
Apr. 18
|
|
ST274, group30_1
|
Wild-type
|
Patient49c
|
C2
|
Apr. 12
|
Unknown
|
Patient32c
|
C2
|
Apr. 18
|
|
ST1197, group25_1
|
Wild-type
|
Patient1
|
C1
|
Aug. 7
|
Unknown
|
Patient13
|
C2
|
Aug. 12
|
|
ST1238, group27_1
|
Wild-type
|
Patient9
|
B5
|
Jul. 22
|
Unknown
|
Patient48
|
A1
|
Jul. 22
|
|
ST3218, group15_1d
|
Wild-type
|
Patient32c
|
C2
|
Apr. 15
|
Unknown
|
Patient49c
|
C2
|
Apr. 18
|
|
ST3218, group15_1d
|
Wild-type
|
Patient8
|
A3
|
Oct. 14
|
→
|
Patient39
|
C2
|
Oct. 22
|
Sink trap to patient
|
|
ST253, group0_6
|
Wild-type
|
Sink trap
|
B2
|
May 13
|
→
|
Patient14
|
A3
|
May 24
|
Patient to sink trap
|
|
ST27, group21_1
|
Wild-type
|
Patient36
|
B3
|
Feb. 23
|
→
|
Sink trap
|
B3
|
Mar. 4
|
|
ST234, group33_1
|
Wild-type
|
Patient5
|
A5
|
May 2
|
→
|
Sink trap
|
A5
|
Jul. 29
|
|
ST253, group0_3
|
Wild-type
|
Patient17
|
A1
|
Oct. 23
|
→
|
Sink trap
|
A1
|
Nov. 4
|
|
ST308, group1_6
|
Wild-type
|
Patient54
|
A2
|
Jul. 8
|
→
|
Sink trap
|
A2
|
Jul. 15
|
|
ST309, group2_3
|
Wild-type
|
Patient10
|
B2
|
Sep. 2
|
→
|
Sink trap
|
B2
|
Sep. 23
|
|
ST671, group32_1
|
Wild-type
|
Patient19
|
A2
|
Mar. 30
|
→
|
Sink trap
|
A2
|
Apr. 8
|
a In cases of transmission between two sampling points ≥ 7 days apart, we defined the older one as the source.
b Isolated low-level resistance to fluoroquinolones.
c Patient32 and Patient49 shared both isolates ST274, group30_1 and ST3218, group15_1.
d ST3218, group15_1 was shared by Patient32 and Patient49 and transmitted from Patient8 to Patient39.
Most of the links occurred within a given sink trap, showing that such niches were contaminated with a signature flora that was stable over time. However, we identified 22 cross-transmission events between sink traps of different rooms, with 10 between sink traps of different subunits (Fig. 2A).
We identified six events of PA cross-transmission between patients, four involving one clonal isolate and one involving two (Table 1, Fig. 2B). These events involved five non-high-risk clones (ST198, ST274, ST1197, ST1238, ST3218) and nine patients. Isolate ST198 group34_1 was shared by two patients hospitalized in room A1 during the same week, but whose hospitalization period did not overlap. Isolates ST1197 group25_1 and ST1238 group27_1 were transmitted between patients hospitalized during the same week in different rooms (C1 and C2 for ST1197, A1 and B5 for ST1238). Two patients from room C2 shared two isolates (ST274 group30_1 and ST3218 group15_1). The temporal proximity of the finding of these isolates prevented the identification of the source of contamination. In one case, we could document the direction of contamination of a patient of room C2 with the isolate ST3218 group15_1 from a patient hospitalized in room A3 (Table 1, Fig. 2B). Overall, four patients shared the isolate ST3218 group15_1: two patients were hospitalized in April 2019 in room C2 and two others six months later in rooms C2 or A3 (Table 1). We never retrieved this isolate from any sink trap (Supplemental Table 1).
In terms of environment-to-patient contamination, only one transmission of a PA isolate occurred from a sink trap to a patient. A high-risk ST253 clone, repeatedly found in the sink trap of rooms B2 and B3 from January to September 2019, was isolated from a patient hospitalized in May in room A3 (Table 1, Fig. 2B). In addition, we identified six transmission events of PA from patients to the sink traps of their rooms (Fig. 2B). The six STs involved (ST27, ST234, ST253, ST308, ST309, ST671) were transmitted in rooms A1, A2, A5, B2, and B3 (Table 1). Overall, among the 65 patients infected or colonized with PA, one patient (1.5%) acquired a PA isolate from a sink trap and five other patients (7.7%) were contaminated with a PA isolate from another patient.
Resistance profiles of P. aeruginosa. The proportion of isolates susceptible to all antibiotics tested was higher for the PA of human origin (74.8%; 86/115) than the PA found in the sink traps (48.0%, 194/404) (Fisher’s exact test, p = 2.8x10-7; Supplemental Table 1). The only clone that produced extended-spectrum β-lactamase (VEB-1) belonged to ST357 and was represented by eight isolates found in the sink trap of room B1. Isolates non-susceptible to carbapenems were more frequently found in sink traps (152/404, 37.6%) than in patients (19/115, 16.5%) (Fisher’s exact test, p = 1.6x10-5). The 13 isolates resistant to all antibiotics tested (Supplemental Table 1) were exclusively retrieved from sink traps and clustered within two clones belonging to ST111 (room C2) and ST357 (room B1).
Four of the five PA isolates transmitted between patients (ST274 group30_1, ST1197 group25_1, ST1238 group27_1, ST3218 group15_1) displayed wildtype resistance profiles. Of note, isolate ST3218 group15_1 was transmitted on two occasions involving four patients. The fifth isolate (ST198 group34_1) displayed an isolated low level of resistance to ciprofloxacin. Finally, the isolate ST253 group0_6 transmitted from a sink drain to a patient had a wildtype resistance profile to antibiotics (Table 1, Supplemental Table 1, Supplemental Fig. 3).